Alendronate is not necessary for most women with post-menopausal osteoporosis after five years of treatment. Portuguese Journal of Family Medicine and General Practice, [S. l.], v. 23, n. 2, p. 238–9, 2007. DOI: 10.32385/rpmgf.v23i2.11133. Disponível em: https://rpmgf.pt/ojs/index.php/rpmgf/article/view/11133. Acesso em: 17 apr. 2026.